Epstein-Barr virus encoded EBNA-3 binds to vitamin D receptor and blocks activation of its target genes

Cellular and Molecular Life Sciences

Volumn 67, Issue 24, 2010, Pages 4249-4256

  Yenamandra, Surya Pavan ^a,f   Hellman, Ulf ^b   Kempkes, Bettina ^c   Darekar, Suhas Deoram ^a   Petermann, Sabine ^c   Sculley, Tom ^d   Klein, George ^a   Kashuba, Elena ^a,e  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Sweden)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^e R E KAVETSKY INSTITUTE OF EXPERIMENTAL PATHOLOGY   (Ukraine)

^f BIOINFORMATICS INSTITUTE   (Singapore)

Author keywords

EBNA; EBV; Transcription regulation; VDR; Vitamin D3

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; EPSTEIN BARR VIRUS ANTIGEN 3; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ANTIGEN BINDING; APOPTOSIS; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE ACTIVATION; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; LYMPHOBLAST; NONHUMAN; NUCLEOTIDE SEQUENCE; TRANSCRIPTION REGULATION; VIROGENESIS; VIRUS CELL INTERACTION;

ANIMALS; CALCIFEDIOL; CELL LINE; CELL LINE, TUMOR; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENE EXPRESSION REGULATION; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOCYTES; MASS SPECTROMETRY; RECEPTORS, CALCITRIOL;

HERPESVIRIDAE; HUMAN HERPESVIRUS 4;

EID: 78651286611     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-010-0441-4     Document Type: Article

References (34)

1. Kieff E, Rikinson A (2001) Epstein-Barr virus and its replication. In: Fields BN (ed) Fields Virology, vol II, 2nd edn. Lippincott Williams & Wilkins, Philadelphia, pp 2511-2574
2. Robertson ES, Grossman S, Johannsen E, Miller C, Lin J, Tomkinson B, Kieff E (1995) Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa. J Virol 69:3108-3116
3. Robertson ES, Lin J, Kieff E (1996) The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, and 3C interact with RBPJ (kappa). J Virol 70:3068-3074
4. Johannsen E, Miller CL, Grossman SR, Kieff E (1996) EBNA-2 and EBNA-3C extensively and mutually exclusively associate with RBPJkappa in Epstein-Barr virus-transformed B lymphocytes. J Virol 70:4179-4183
5. Zhao B, Marshall DR, Sample CE (1996) A conserved domain of the Epstein-Barr virus nuclear antigens 3A and 3C binds to a discrete domain of Jkappa. J Virol 70:4228-4236
6. Krauer K, Kienzle N, Young DB, Sculley TB (1996) Epstein-Barr nuclear antigen-3 and -4 interact with RBP-2N, a major isoform of RBP-J kappa in B lymphocytes. Virology 226:346-353
7. Le Roux A, Kerdiles B, Walls D, Dedieu JF, Perricaudet M (1994) The Epstein-Barr virus determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter. Virology 205:596-602
8. Cludts I, Farrell PJ (1998) Multiple functions within the Epstein-Barr virus EBNA-3A protein. J Virol 72:1862-1869
9. Cooper A, Johannsen E, Maruo S, Cahir-McFarland E, Illanes D, Davidson D, Kieff E (2003) EBNA3A association with RBP-Jkappa down-regulates c-myc and Epstein-Barr virus-transformed lymphoblast growth. J Virol 77:999-1010
10. Kashuba EV, Gradin K, Isaguliants M, Szekely L, Poellinger L, Klein G, Kazlauskas A (2006) Regulation of transactivation function of the aryl hydrocarbon receptor by the Epstein-Barr virus-encoded EBNA-3 protein. J Biol Chem 281:1215-1223
11. Kashuba E, Kashuba V, Pokrovskaja K, Klein G, Szekely L (2000) Epstein-Barr virus encoded nuclear protein EBNA-3 binds XAP-2, a protein associated with Hepatitis B virus X antigen. Oncogene 19:1801-1806
12. Yenamandra SP, Klein G, Kashuba E (2009) Nuclear receptors and their role in Epstein-Barr virus induced B cell transformation. Exp Oncol 31:67-73
13. Yenamandra SP, Lundin A, Arulampalam G, Yurchenko M, Pettersson S, Klein G, Kashuba E (2009) Expression profile of nuclear receptors upon Epstein-Barr virus induced B cell transformation. Exp Oncol 31:92-96
14. Buck M, Burgess A, Stirzaker R, Krauer K, Sculley T (2006) Epstein-Barr virus nuclear antigen 3A contains six nuclearlocalization signals. J Gen Virol 87:2879-2884
15. Hertle ML, Popp C, Peterman S, Maier S, Kremmer E, Lang R, Mages J, Kempkes B (2009) Differential gene expression patterns of EBV infected EBNA-3A positive and negative human B lymphocytes. PLoS Pathog 5: e1000506
16. Hellman U (2002) Peptide mapping using MALDI-TOFMS. Wiley, Inc, New York
17. Hellman U, Bhikhabhai R (2002) Easy amino acid sequencing of sulfonated peptides using post-source decay on a matrix-assisted laser desorption/ ionization time-of-flight mass spectrometer equipped with a variable voltage reflector. Rapid Commun Mass Spectrom 16:1851-1859
18. Kitagawa H, Fujiki R, Yoshimura K, Mezaki Y, Uematsu Y, Matsui D, Ogawa S, Unno K, Okubo M, Tokita A, Nakagawa T, Ito T, Ishimi Y, Nagasawa H, Matsumoto T, Yanagisawa J, Kato S (2003) The chromatin-remodeling complex WINAC targets a nuclear receptor to promoters and is impaired in Williams syndrome. Cell 113:905-917
19. Gregory CD, Dive C, Henderson S, Smith CA, Williams GT, Gordon J, Rickinson AB (1991) Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature 349:612-614
20. Lee JM, Lee KH, Farrell CJ, Ling PD, Kempkes B, Park JH, Hayward SD (2004) EBNA2 is required for protection of latently Epstein-Barr virus-infected B cells against specific apoptotic stimuli. J Virol 78:12694-12697
21. Lee JM, Lee KH, Weidner M, Osborne BA, Hayward SD (2002) Epstein-Barr virus EBNA2 blocks Nur77-mediated apoptosis. Proc Natl Acad Sci USA 99:11878-11883
22. Pegman PM, Smith SM, D'Souza BN, Loughran ST, Maier S, Kempkes B, Cahill PA, Simmons MJ, Gelinas C, Walls D (2006) Epstein-Barr virus nuclear antigen 2 trans-activates the cellular antiapoptotic bfl-1 gene by a CBF1/RBPJ kappa-dependent pathway. J Virol 80:8133-8144
23. Horndasch M, Raschke EE, Bommer G, Schuhmacher M, Dumont E, Kuklik-Roos C, Eick D, Kempkes B (2002) Epstein-Barr virus antagonizes the antiproliferative activity of transforming growth factor-beta but does not abolish its signaling. Int J Cancer 101:442-447
24. Kelly GL, Milner AE, Tierney RJ, Croom-Carter DS, Altmann M, Hammerschmidt W, Bell AI, Rickinson AB (2005) Epstein-Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A, -3B, and -3C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis. J Virol 79:10709-10717
25. Anderton E, Yee J, Smith P, Crook T, White RE, Allday MJ (2008) Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma. Oncogene 27:421-433
26. Jurutka PW, Remus LS, Whitfield GK, Thompson PD, Hsieh JC, Zitzer H, Tavakkoli P, Galligan MA, Dang HT, Haussler CA, Haussler MR (2000) The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB. Mol Endocrinol 14:401-420
27. Norman AW (2006) Minireview: vitamin D receptor: new assignments for an already busy receptor. Endocrinology 147:5542-5548
28. Gombart AF, Luong QT, Koeffler HP (2006) Epstein-Barr virus antagonizes the antiproliferative activity of transforming growth factor-beta but does not abolish its signaling. Anticancer Res 26:2531-2542
29. Banerjee P, Chatterjee M (2003) Antiproliferative role of vitamin D and its analogs-a brief overview. Mol Cell Biochem 253:247-254
30. Dusso AS, Brown AJ, Slatopolsky E (2005) Vitamin D. Am J Physiol Renal Physiol 289: F8-28
31. Morgan JW, Reddy GS, Uskokovic MR, May BK, Omdahl JL, Maizel AL, Sharma S (1994) Functional block for 1 alpha, 25-dihydroxy vitamin D3-mediated gene regulation in human B lymphocytes. J Biol Chem 269:13437-13443
32. Morgan JW, Kouttab N, Ford D, Maizel AL (2000) Vitamin D-mediated gene regulation in phenotypically defined human B cell subpopulations. Endocrinology 141:3225-3234
33. Elstner E, Lee YY, Hashiya M, Pakkala S, Binderup L, Norman AW, Okamura WH, Koeffler HP (1994) 1 alpha, 25-Dihydroxy-20-epi-vitamin D3: an extraordinarily potent inhibitor of leukemic cell growth in vitro. Blood 84:1960-1967
34. Jones G, Strugnell SA, DeLuca HF (1998) Current understanding of the molecular actions of vitamin D. Physiol Rev 78:1193-1231